The bioinformatics analysis of SAE1 from these two databases demonstrated that high expression of SAE1 is associated with poor survival and prognosis of patients suffering from glioma, liver cancer, renal cancer and thyroid cancer (Additional file 2: Figure S2A, S2B). This evidence concerns the gene SAE1 and renal carcinoma.